raloxifene hydrochloride has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bours, V; Castermans, E; Chariot, A; Close, P; de Leval, L; Franchimont, N; Malaise, M; Merville, MP; Olivier, S; Tabruyn, S | 1 |
1 other study(ies) available for raloxifene hydrochloride and Multiple Myeloma
| Article | Year |
|---|---|
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; NF-kappa B; Polymerase Chain Reaction; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2006 |